These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7703045)

  • 21. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia.
    Karp JE; Dick JD; Angelopulos C; Charache P; Green L; Burke PJ; Saral R
    Am J Med; 1986 Aug; 81(2):237-42. PubMed ID: 3526884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial.
    Benhamou E; Hartmann O; Noguès C; Maraninchi D; Valteau D; Lemerle J
    Bone Marrow Transplant; 1991 Feb; 7(2):127-31. PubMed ID: 2049556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
    Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit.
    Kirkpatrick BD; Harrington SM; Smith D; Marcellus D; Miller C; Dick J; Karanfil L; Perl TM
    Clin Infect Dis; 1999 Nov; 29(5):1268-73. PubMed ID: 10524974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infectious complications of human bone marrow transplantation.
    Winston DJ; Gale RP; Meyer DV; Young LS
    Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
    Rolston KV; Nguyen H; Amos G; Elting L; Fainstein V; Bodey GP
    J Infect Dis; 1994 Feb; 169(2):350-5. PubMed ID: 8106768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
    Corey GR; Good S; Jiang H; Moeck G; Wikler M; Green S; Manos P; Keech R; Singh R; Heller B; Bubnova N; O'Riordan W;
    Clin Infect Dis; 2015 Jan; 60(2):254-62. PubMed ID: 25294250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
    Kargar Samani K; Vandercam B; Straetmans N; Michaux L; Ferrant A
    Acta Clin Belg; 2000; 55(5):279-84. PubMed ID: 11109643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic granulocyte transfusions during human bone marrow transplantation.
    Winston DJ; Ho WG; Young LS; Gale RP
    Am J Med; 1980 Jun; 68(6):893-7. PubMed ID: 6247910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
    Cruciani M; Rampazzo R; Malena M; Lazzarini L; Todeschini G; Messori A; Concia E
    Clin Infect Dis; 1996 Oct; 23(4):795-805. PubMed ID: 8909847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
    Archimbaud E; Guyotat D; Maupas J; Ploton C; Nageotte A; Devaux Y; Thomas X; Fleurette J; Fiere D
    Eur J Cancer; 1991; 27(2):174-8. PubMed ID: 1827284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.
    Liang R; Lau GK; Kwong YL
    J Clin Oncol; 1999 Jan; 17(1):394-8. PubMed ID: 10458258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of efficacy and safety of linezolid versus vancomycin for the treatment of infections in patients after allogeneic hematopoietic stem cell transplantation].
    Tian J; Xu Z; Liu D; Huang X; Liu K; Chen H; Chen Y; Chen Y; Zhang X; Han W; Zhang Y; Wang F; Wang Y; Yan C; Xu L
    Zhonghua Nei Ke Za Zhi; 2016 Feb; 55(2):97-101. PubMed ID: 26875576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Teicoplanin pharmacokinetics in pediatric patients.
    Dufort G; Ventura C; Olivé T; Ortega JJ
    Pediatr Infect Dis J; 1996 Jun; 15(6):494-8. PubMed ID: 8783345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study.
    Engelhard D; Elishoov H; Strauss N; Naparstek E; Nagler A; Simhon A; Raveh D; Slavin S; Or R
    Transplantation; 1996 Feb; 61(3):430-4. PubMed ID: 8610356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not all patients with vancomycin-resistant enterococci need to be isolated.
    Tschudin Sutter S; Frei R; Dangel M; Gratwohl A; Bonten M; Widmer AF
    Clin Infect Dis; 2010 Sep; 51(6):678-83. PubMed ID: 20687839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.